Tango Therapeutics vs Zentalis Pharmaceuticals
TNGX and ZNTL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How TNGX and ZNTL compare
Tango Therapeutics is the larger company, worth 38 times as much as Zentalis Pharmaceuticals ($3.7B against $97.5M).
Tango Therapeutics scores higher on the StockData Score (10 against 6 for Zentalis Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | TNGX | ZNTL |
|---|---|---|
| Size and price | ||
| Market cap | $3.7B | $97.5M |
| Share price | $21.89 | $1.36 |
| Change, 1 year | 174% | 3.0% |
| Change, 5 years | 111% | −98.2% |
| Beta (5Y) | 1.19 | 2.18 |
| Employees | 137 | 106 |
| StockData Score | ||
| Total score | 10 (better) | 6 |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 2 (better) | 0 |
| Health score | 6 (better) | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 68.6× | – |
| P/B | 3.6× | 0.7× (better) |
| FCF yield | −3.9% (better) | −131% |
| Fair value | $9.68 | – |
| Margin of safety | −126% | – |
| Growth | ||
| Revenue growth (TTM) | 121% | – |
| Revenue growth, 5Y average | 52.1% | – |
| Profitability | ||
| Operating margin | −253% | – |
| Net margin | −230% | – |
| FCF margin | −268% | – |
| Return on equity | −21.3% (better) | −66.7% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 50.82 (better) | 4.82 |
| Altman Z-score | 44.72 (better) | −8.99 |
| Piotroski F-score | 4 (better) | 1 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 127% | 66.1% |
| Held by insiders | 11.7% | 58.0% |
| Insider net buying, 12 months | −$8.1M | $12.8M (better) |
| Short interest, % of float | 32.4% | 16.7% |
Go deeper
- TNGX stock overview
- TNGX income statement
- TNGX valuation and score
- ZNTL stock overview
- ZNTL income statement
- ZNTL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.